About this item
Product details
Managing type 2 diabetes mellitus. Improving glycemic control. Reducing HbA1c levels. Minimizing the risk of cardiovascular events in diabetic patients. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, used in the management of type 2 diabetes mellitus. As a selective and potent DPP-4 inhibitor, it enhances glycemic control by increasing endogenous incretin hormones, such as GLP-1 and GIP, which stimulate insulin release and reduce glucagon secretion. Linagliptin is characterized by its once-daily dosing regimen, a low potential for drug-drug interactions, and a favorable side effect profile. It is a valuable therapeutic option for individuals with type 2 diabetes who require adjunctive treatment to improve blood glucose control while minimizing the risk of hypoglycemia and other adverse effects. Composition Each film coated tablet contains: Linagliptin: 5 mg Directions for Use Use only as directed by the physician.
- Medicine
- 10 Film Coated Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicine
- Brand
- CCL
- SKU
- 8961101622831
- Variant
- 10 Film Coated Tablets
- Tags
- Blood Glucose, Linagliptin, Medicine, Type 2 Diabetes
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
